Catalent Launches Qai, Enterprise AI Platform to Advance Quality Management Across Global Manufacturing Network

Catalent, Inc., the leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives...

June 18, 2026 | Thursday | News
IDBS and Alchemi Partner to Accelerate AI-Driven Regulatory Submissions in Biopharma

IDBS, a Danaher company and leading provider of cloud software for biopharma, and Alchemi, a leading applied AI company serving the world's largest pharm...

June 18, 2026 | Thursday | News
Jetstream Venture Fund Secures Early Access to Rejuvenate Bio’s Longevity Gene Therapy Platform

Jetstream Venture Fund (Jetstream), an innovative interval fund dedicated to opening access to institutional-grade deal flow for a wider mainstream audienc...

June 18, 2026 | Thursday | News
Opus Genetics Showcases Expanding Inherited Retinal Disease Gene Therapy Pipeline with Five Programs Advancing Toward Key Clinical Milestones

Rapidly Advancing Five IRD Programs with Four Clinical Data Readouts Expected in 2027 RDH12, MERTK and RHO Programs Expected to Enter Clinical Testing o...

June 18, 2026 | Thursday | News
Bayer Completes Acquisition of Perfuse Therapeutics, Securing Full Rights to Phase II Ophthalmology Candidate PER-001

Bayer announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer...

June 18, 2026 | Thursday | News
Hillhurst Bio Doses First Patient in Phase 2a Trial of HBI-002 for Parkinson’s Disease

Hillhurst Biopharmaceuticals Inc. ("Hillhurst Bio"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products bas...

June 17, 2026 | Wednesday | News
Lonza and Antharis Therapeutics Partner to Develop Next-Generation Dual-Payload ADCs for GI Cancers

Target-specific licensing agreement enabling Antharis to advance proprietary dual-payload antibody-drug conjugate (ADC) progra...

June 17, 2026 | Wednesday | News
VIVEbiotech Reaches Milestone with 15th In Vivo Lentiviral Vector Program, Reinforcing Leadership in Gene Therapy Manufacturing

VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO),  underscored its industry leadership in the dev...

June 17, 2026 | Wednesday | News
ZoBio Launches Integrated DNA-Encoded Library Hit Discovery Service to Accelerate Drug Discovery Against Challenging Targets

ZoBio, a boutique problem-solving Contract Research Organization (CRO) specializing in early gene-to-lead discovery, today announced the launch of its co...

June 17, 2026 | Wednesday | News
Quintara Biosciences Relocates Boston-Area Laboratory to Watertown to Expand Sequencing Capacity

As a strategic step to better support growing demand and strengthen future service capacity, Quintara Biosciences announced that its Boston area laboratory...

June 15, 2026 | Monday | News
Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy in Pancreatic Cancer Trial

Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, announc...

June 12, 2026 | Friday | News
T-CURX Secures First Clinical Trial Approval for TCX-001, Advancing Novel Non-Viral CAR-T Therapy into the Clinic

Clinical Trial approval for TCX-001 is another significant development milestone for T-CURX and marks the transition of T-CURX from a pre-clinical to a...

June 12, 2026 | Friday | News
Lung Cancer Research Foundation and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment and Patient Advocacy

The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca,  announced that two research awards focused on improving outcomes for...

June 11, 2026 | Thursday | News
AcCELLerated Biologics Partners with Forever Labs to Expand Access to Stem Cell Banking and Personalized Regenerative Therapies

Leading regenerative medicine innovators unite to deliver seamless stem cell banking and personalized biologic solutions for physicians and patients nati...

June 11, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close